JPWO2022120137A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022120137A5 JPWO2022120137A5 JP2023533830A JP2023533830A JPWO2022120137A5 JP WO2022120137 A5 JPWO2022120137 A5 JP WO2022120137A5 JP 2023533830 A JP2023533830 A JP 2023533830A JP 2023533830 A JP2023533830 A JP 2023533830A JP WO2022120137 A5 JPWO2022120137 A5 JP WO2022120137A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- hvr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063121629P | 2020-12-04 | 2020-12-04 | |
| US63/121,629 | 2020-12-04 | ||
| PCT/US2021/061755 WO2022120137A1 (en) | 2020-12-04 | 2021-12-03 | Compositions and methods for treating ocular diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023551734A JP2023551734A (ja) | 2023-12-12 |
| JPWO2022120137A5 true JPWO2022120137A5 (https=) | 2024-12-10 |
| JP2023551734A5 JP2023551734A5 (https=) | 2024-12-10 |
Family
ID=81853584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533830A Pending JP2023551734A (ja) | 2020-12-04 | 2021-12-03 | 眼の疾患を治療するための組成物及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240059765A1 (https=) |
| EP (1) | EP4255485A4 (https=) |
| JP (1) | JP2023551734A (https=) |
| KR (1) | KR20230117192A (https=) |
| CN (1) | CN116782940A (https=) |
| AU (1) | AU2021391800A1 (https=) |
| CA (1) | CA3200976A1 (https=) |
| CL (1) | CL2023001596A1 (https=) |
| IL (1) | IL303289A (https=) |
| MX (1) | MX2023006591A (https=) |
| WO (1) | WO2022120137A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015006507A1 (en) | 2013-07-09 | 2015-01-15 | Annexon, Inc. | Methods of treatment for alzheimer's disease and huntington's disease |
| WO2017091719A1 (en) | 2015-11-24 | 2017-06-01 | Annexon, Inc. | Anti-complement factor c1q fab fragments and uses thereof |
| WO2023114763A1 (en) | 2021-12-13 | 2023-06-22 | Annexon, Inc. | Anti-complement factor c1q antibodies with single binding arms and uses thereof |
| KR20250006238A (ko) * | 2022-04-29 | 2025-01-10 | 애넥슨, 인코포레이티드 | 안구 질환을 치료하기 위한 조성물 및 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015006507A1 (en) * | 2013-07-09 | 2015-01-15 | Annexon, Inc. | Methods of treatment for alzheimer's disease and huntington's disease |
| WO2017091719A1 (en) * | 2015-11-24 | 2017-06-01 | Annexon, Inc. | Anti-complement factor c1q fab fragments and uses thereof |
-
2021
- 2021-12-03 WO PCT/US2021/061755 patent/WO2022120137A1/en not_active Ceased
- 2021-12-03 CN CN202180090142.XA patent/CN116782940A/zh active Pending
- 2021-12-03 IL IL303289A patent/IL303289A/en unknown
- 2021-12-03 US US18/265,380 patent/US20240059765A1/en active Pending
- 2021-12-03 MX MX2023006591A patent/MX2023006591A/es unknown
- 2021-12-03 AU AU2021391800A patent/AU2021391800A1/en active Pending
- 2021-12-03 EP EP21901508.8A patent/EP4255485A4/en active Pending
- 2021-12-03 CA CA3200976A patent/CA3200976A1/en active Pending
- 2021-12-03 JP JP2023533830A patent/JP2023551734A/ja active Pending
- 2021-12-03 KR KR1020237022463A patent/KR20230117192A/ko active Pending
-
2023
- 2023-06-02 CL CL2023001596A patent/CL2023001596A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106102837B (zh) | 双特异性hiv-1-中和抗体 | |
| JP2025143348A (ja) | ポリオーマウイルス中和抗体 | |
| JPWO2021183359A5 (https=) | ||
| JP2017534646A5 (https=) | ||
| JP2018527887A5 (https=) | ||
| CA3118777A1 (en) | Methods of treating graves' ophthalmopathy using anti-fcrn antibodies | |
| CA3176436A1 (en) | Bispecific antibodies against cd3 and cd20 | |
| JP2021535758A5 (https=) | ||
| CN107108727A (zh) | 对人vegf‑a有异常强的结合亲和力并具有与人vegf‑b的交叉反应性的抗人vegf抗体 | |
| JP2021515793A5 (https=) | ||
| JP2017534645A5 (https=) | ||
| TW202342095A (zh) | 用於治療和預防ｃｏｖｉｄ—１９之組成物 | |
| JP2022500382A5 (https=) | ||
| JPWO2022120137A5 (https=) | ||
| JPWO2022053655A5 (https=) | ||
| JPWO2020180819A5 (https=) | ||
| JPWO2022053656A5 (https=) | ||
| JPWO2021224499A5 (https=) | ||
| JPWO2020128049A5 (https=) | ||
| JPWO2022053653A5 (https=) | ||
| JPWO2023122714A5 (https=) | ||
| IL316218A (en) | Preparations and methods for treating eye diseases | |
| JPWO2022053658A5 (https=) | ||
| KR20240135698A (ko) | 개파보바이러스 특이적 항체 cpv-b3 및 이를 포함하는 개파보바이러스 감염증 치료용 약제학적 조성물 | |
| JPWO2022098648A5 (https=) |